Clozapine-N-oxide, 1GM (CAT# C587520)
Ended Awarded
- Contract number
- HHSN26700001
- Awardee
-
Enzo Life Sciences International, Inc. UEI ELAJVLXNEKN8
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,000
Award facts
- Contract value
-
- $4,000.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26700001?
HHSN26700001 was awarded to Enzo Life Sciences International, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on July 31, 2007.
How much is contract HHSN26700001 worth?
The government has obligated $4,000 on HHSN26700001.
Is contract HHSN26700001 an order under another contract?
Yes. HHSN26700001 is a BPA call under HHSN263200400060800B, a blanket purchase agreement.
Was contract HHSN26700001 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award